Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals

Journal of Clinical Microbiology

Volumn 40, Issue 5, 2002, Pages 1603-1609

  Hermann, Corinna ^a   Graf, Kathrin ^a   Groh, Annemarie ^a   Straube, Eberhard ^a   Hartung, Thomas ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROPREVALENCE;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; AUTOMATION; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; LABORATORIES; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; RICKETTSIALES;

EID: 0036246199     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.5.1603-1609.2002     Document Type: Article

References (52)

1. Chlamydia pneumoniae infection in human monocytes
2. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979
3. Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells
4. Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens
5. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection
6. Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas
7. Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells
8. Chlamydial lipopolysaccharide
9. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen
10. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells
11. Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS)
12. Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis
13. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atheroscelerosis
14. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland
15. The association of Chlamydia pneumoniae infection and reactive airway disease in children
16. Persistent Chlamydia pneumoniae infection in a Swedish family
17. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis
18. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
19. Chlamydia pneumoniae sp. nov. for Chlamydia sp. strain TWAR
20. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections
21. Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983
22. Chlamydia pneumoniae infections
23. Persistent infection with Chlamydia pneumoniae following acute respiratory illness
24. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: Assessment by polymerase chain reaction-enzyme immunoassay and culture
25. Pneumonia due to Chlamydia pneumoniae: Prevalence, clinical features, diagnosis, and treatment
26. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity
27. Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model
28. Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection
29. Chlamydia pneumoniae and chronic lung diseases
30. Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction
31. Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells
32. Differential expression of ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and interferon-gamma treated cultures of Chlamydia pneumoniae
33. Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae
34. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults
35. Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections
36. Persistence of Chlamydia pneumoniae, strain TWAR micro-immunofluorescent antibody
37. Chlamydia pneumoniae serology: Interlaboratory variation in microimmunofluorescence assay results
38. Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae
39. Evaluation of a commercial test for antibodies to the chlamydial lipopolysaccharide (Medac) for serodiagnosis of acute infections by Chlamydia pneumoniae (TWAR) and Chlamydia psittaci
40. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae
41. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
42. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
43. Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan acute respiratory) seropositivity
44. Chlamydia pneumoniae serology: Importance of methodology in patients with coronary heart disease and healthy individuals
45. Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens
46. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA
47. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections
48. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual
49. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test
50. The similarity of Chlamydia pneumoniae (TWAR) isolates as antigen in the microimmunofluorescence (MIF) test
51. Chlamydia pneumoniae and atherosclerosis
52. Chlamydia pneumoniae infection of the central nervous system